FDA warns Emergent BioSolutions over GMP violations at Camden facility
Regulatory NewsJeff Craven
Audit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyNorth AmericaRegulatory NewsJeff CravenAudit/inspectionBiologics/ biosimilars/ vaccinesBiotechnologyNorth America